UniProt ID | SAMD1_HUMAN | |
---|---|---|
UniProt AC | Q6SPF0 | |
Protein Name | Atherin | |
Gene Name | SAMD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 538 | |
Subcellular Localization | Cytoplasm . Secreted . | |
Protein Description | May play a role in atherogenesis by immobilizing LDL in the atherial wall.. | |
Protein Sequence | MAGPPALPPPETAAAATTAAAASSSAASPHYQEWILDTIDSLRSRKARPDLERICRMVRRRHGPEPERTRAELEKLIQQRAVLRVSYKGSISYRNAARVQPPRRGATPPAPPRAPRGAPAAAAAAAPPPTPAPPPPPAPVAAAAPARAPRAAAAAATAPPSPGPAQPGPRAQRAAPLAAPPPAPAAPPAVAPPAGPRRAPPPAVAAREPPLPPPPQPPAPPQQQQPPPPQPQPPPEGGAVRAGGAARPVSLREVVRYLGGSGGAGGRLTRGRVQGLLEEEAAARGRLERTRLGALALPRGDRPGRAPPAASARPSRSKRGGEERVLEKEEEEDDDEDEDEEDDVSEGSEVPESDRPAGAQHHQLNGERGPQSAKERVKEWTPCGPHQGQDEGRGPAPGSGTRQVFSMAAMNKEGGTASVATGPDSPSPVPLPPGKPALPGADGTPFGCPPGRKEKPSDPVEWTVMDVVEYFTEAGFPEQATAFQEQEIDGKSLLLMQRTDVLTGLSIRLGPALKIYEHHIKVLQQGHFEDDDPDGFLG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | PALPPPETAAAATTA CCCCCHHHHHHHHHH | 27.63 | 22210691 | |
17 | Phosphorylation | PETAAAATTAAAASS HHHHHHHHHHHHHHH | 16.55 | 22210691 | |
18 | Phosphorylation | ETAAAATTAAAASSS HHHHHHHHHHHHHHC | 15.01 | 22210691 | |
23 | Phosphorylation | ATTAAAASSSAASPH HHHHHHHHHCCCCHH | 21.79 | 28464451 | |
24 | Phosphorylation | TTAAAASSSAASPHY HHHHHHHHCCCCHHH | 21.19 | 28348404 | |
25 | Phosphorylation | TAAAASSSAASPHYQ HHHHHHHCCCCHHHH | 25.92 | 28348404 | |
28 | Phosphorylation | AASSSAASPHYQEWI HHHHCCCCHHHHHHH | 16.36 | 25159151 | |
31 | Phosphorylation | SSAASPHYQEWILDT HCCCCHHHHHHHHHH | 16.12 | - | |
46 | Sumoylation | IDSLRSRKARPDLER HHHHHHHCCCCCHHH | 50.42 | - | |
46 | Sumoylation | IDSLRSRKARPDLER HHHHHHHCCCCCHHH | 50.42 | - | |
75 | Ubiquitination | RTRAELEKLIQQRAV HHHHHHHHHHHHHCC | 64.61 | - | |
86 | Phosphorylation | QRAVLRVSYKGSISY HHCCCEEEECCCEEE | 18.07 | 23186163 | |
87 | Phosphorylation | RAVLRVSYKGSISYR HCCCEEEECCCEEEE | 19.26 | - | |
88 | Acetylation | AVLRVSYKGSISYRN CCCEEEECCCEEEEC | 38.38 | 25953088 | |
88 | Ubiquitination | AVLRVSYKGSISYRN CCCEEEECCCEEEEC | 38.38 | - | |
88 | Methylation | AVLRVSYKGSISYRN CCCEEEECCCEEEEC | 38.38 | 115977517 | |
90 | Phosphorylation | LRVSYKGSISYRNAA CEEEECCCEEEECCC | 12.28 | - | |
92 | Phosphorylation | VSYKGSISYRNAARV EEECCCEEEECCCCC | 21.53 | - | |
93 | Phosphorylation | SYKGSISYRNAARVQ EECCCEEEECCCCCC | 13.25 | - | |
104 | Methylation | ARVQPPRRGATPPAP CCCCCCCCCCCCCCC | 44.89 | 54559047 | |
107 | Phosphorylation | QPPRRGATPPAPPRA CCCCCCCCCCCCCCC | 32.40 | 23927012 | |
116 | Methylation | PAPPRAPRGAPAAAA CCCCCCCCCCCCHHH | 53.58 | 115493235 | |
130 | Phosphorylation | AAAAPPPTPAPPPPP HHCCCCCCCCCCCCC | 37.54 | 23312004 | |
144 | Phosphorylation | PAPVAAAAPARAPRA CCCCHHCCCCCCHHH | 8.11 | - | |
151 | Phosphorylation | APARAPRAAAAAATA CCCCCHHHHHHHHCC | 10.61 | - | |
155 | Phosphorylation | APRAAAAAATAPPSP CHHHHHHHHCCCCCC | 10.71 | 20068231 | |
157 | Phosphorylation | RAAAAAATAPPSPGP HHHHHHHCCCCCCCC | 34.66 | 30278072 | |
161 | Phosphorylation | AAATAPPSPGPAQPG HHHCCCCCCCCCCCC | 41.24 | 29255136 | |
166 | Methylation | PPSPGPAQPGPRAQR CCCCCCCCCCCHHCC | 46.76 | - | |
170 | Methylation | GPAQPGPRAQRAAPL CCCCCCCHHCCCCCC | 49.63 | 115493229 | |
178 | Methylation | AQRAAPLAAPPPAPA HCCCCCCCCCCCCCC | 19.50 | - | |
180 | Methylation | RAAPLAAPPPAPAAP CCCCCCCCCCCCCCC | 29.78 | - | |
185 | Methylation | AAPPPAPAAPPAVAP CCCCCCCCCCCCCCC | 34.41 | - | |
197 | Methylation | VAPPAGPRRAPPPAV CCCCCCCCCCCCCCC | 46.61 | 115387211 | |
209 | Phosphorylation | PAVAAREPPLPPPPQ CCCCCCCCCCCCCCC | 30.12 | 19007248 | |
239 | Phosphorylation | QPPPEGGAVRAGGAA CCCCCCCCCCCCCCC | 9.85 | 19007248 | |
242 | Phosphorylation | PEGGAVRAGGAARPV CCCCCCCCCCCCCCC | 17.74 | - | |
250 | Phosphorylation | GGAARPVSLREVVRY CCCCCCCCHHHHHHH | 25.13 | 23186163 | |
257 | Phosphorylation | SLREVVRYLGGSGGA CHHHHHHHHCCCCCC | 9.70 | 24732914 | |
261 | Phosphorylation | VVRYLGGSGGAGGRL HHHHHCCCCCCCCCC | 32.05 | 26055452 | |
272 | Ubiquitination | GGRLTRGRVQGLLEE CCCCCHHHHHHHHHH | 17.81 | - | |
272 | Methylation | GGRLTRGRVQGLLEE CCCCCHHHHHHHHHH | 17.81 | 115493241 | |
275 | Phosphorylation | LTRGRVQGLLEEEAA CCHHHHHHHHHHHHH | 29.40 | - | |
284 | Methylation | LEEEAAARGRLERTR HHHHHHHCCCCCHHH | 26.49 | 54559041 | |
286 | Methylation | EEAAARGRLERTRLG HHHHHCCCCCHHHCC | 28.02 | 115493247 | |
291 | Methylation | RGRLERTRLGALALP CCCCCHHHCCEEECC | 37.03 | 54559059 | |
310 | Phosphorylation | PGRAPPAASARPSRS CCCCCCCHHCCCCCC | 14.97 | - | |
315 | Phosphorylation | PAASARPSRSKRGGE CCHHCCCCCCCCCCC | 43.57 | 19007248 | |
319 | Phosphorylation | ARPSRSKRGGEERVL CCCCCCCCCCCCCCC | 60.64 | - | |
321 | Phosphorylation | PSRSKRGGEERVLEK CCCCCCCCCCCCCCH | 37.31 | - | |
329 | Ubiquitination | EERVLEKEEEEDDDE CCCCCCHHHHCCCCC | 62.35 | - | |
338 | Phosphorylation | EEDDDEDEDEEDDVS HCCCCCCCCCCCCCC | 66.33 | 20068231 | |
345 | Phosphorylation | EDEEDDVSEGSEVPE CCCCCCCCCCCCCCH | 43.14 | 29496963 | |
348 | Phosphorylation | EDDVSEGSEVPESDR CCCCCCCCCCCHHCC | 31.22 | 30576142 | |
353 | Phosphorylation | EGSEVPESDRPAGAQ CCCCCCHHCCCCCHH | 32.61 | 21406692 | |
372 | Phosphorylation | NGERGPQSAKERVKE CCCCCCHHHHHHHHH | 44.43 | 21406692 | |
378 | Ubiquitination | QSAKERVKEWTPCGP HHHHHHHHHCCCCCC | 54.47 | 29967540 | |
381 | Phosphorylation | KERVKEWTPCGPHQG HHHHHHCCCCCCCCC | 15.14 | 24732914 | |
385 | Sumoylation | KEWTPCGPHQGQDEG HHCCCCCCCCCCCCC | 24.28 | - | |
399 | Phosphorylation | GRGPAPGSGTRQVFS CCCCCCCCCHHHHEE | 35.61 | 24732914 | |
401 | Phosphorylation | GPAPGSGTRQVFSMA CCCCCCCHHHHEEEE | 21.45 | 24732914 | |
408 | Ubiquitination | TRQVFSMAAMNKEGG HHHHEEEEEECCCCC | 11.45 | - | |
415 | Ubiquitination | AAMNKEGGTASVATG EEECCCCCEEEEECC | 21.14 | - | |
416 | Phosphorylation | AMNKEGGTASVATGP EECCCCCEEEEECCC | 26.98 | 29255136 | |
418 | Phosphorylation | NKEGGTASVATGPDS CCCCCEEEEECCCCC | 16.48 | 23401153 | |
421 | Phosphorylation | GGTASVATGPDSPSP CCEEEEECCCCCCCC | 47.28 | 29255136 | |
425 | Phosphorylation | SVATGPDSPSPVPLP EEECCCCCCCCCCCC | 30.34 | 23401153 | |
427 | Phosphorylation | ATGPDSPSPVPLPPG ECCCCCCCCCCCCCC | 42.34 | 23401153 | |
435 | Ubiquitination | PVPLPPGKPALPGAD CCCCCCCCCCCCCCC | 32.65 | 29967540 | |
444 | Phosphorylation | ALPGADGTPFGCPPG CCCCCCCCCCCCCCC | 18.91 | 25159151 | |
514 | Ubiquitination | IRLGPALKIYEHHIK CCCCHHHHHHHHHHH | 45.40 | - | |
516 | Phosphorylation | LGPALKIYEHHIKVL CCHHHHHHHHHHHHH | 13.97 | 29496907 | |
521 | Ubiquitination | KIYEHHIKVLQQGHF HHHHHHHHHHHCCCC | 32.32 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SAMD1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SAMD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SAMD1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
XIAP_HUMAN | XIAP | physical | 26496610 | |
CLCN7_HUMAN | CLCN7 | physical | 26496610 | |
DSG1_HUMAN | DSG1 | physical | 26496610 | |
ECT2_HUMAN | ECT2 | physical | 26496610 | |
NDUB5_HUMAN | NDUFB5 | physical | 26496610 | |
RENT1_HUMAN | UPF1 | physical | 26496610 | |
SDCB1_HUMAN | SDCBP | physical | 26496610 | |
TLN1_HUMAN | TLN1 | physical | 26496610 | |
CIP4_HUMAN | TRIP10 | physical | 26496610 | |
TRI14_HUMAN | TRIM14 | physical | 26496610 | |
PDCD6_HUMAN | PDCD6 | physical | 26496610 | |
CDIPT_HUMAN | CDIPT | physical | 26496610 | |
PUM2_HUMAN | PUM2 | physical | 26496610 | |
HIG1A_HUMAN | HIGD1A | physical | 26496610 | |
MYOF_HUMAN | MYOF | physical | 26496610 | |
PCF11_HUMAN | PCF11 | physical | 26496610 | |
IWS1_HUMAN | IWS1 | physical | 26496610 | |
KI18A_HUMAN | KIF18A | physical | 26496610 | |
USMG5_HUMAN | USMG5 | physical | 26496610 | |
PP4P1_HUMAN | TMEM55B | physical | 26496610 | |
R3HC1_HUMAN | R3HCC1 | physical | 26496610 | |
REEP3_HUMAN | REEP3 | physical | 26496610 | |
NSE2_HUMAN | NSMCE2 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-107 AND SER-161, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-107; SER-161 ANDSER-261, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-107; SER-161; SER-315AND SER-345, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND MASSSPECTROMETRY. |